Bio-Path Holdings, Inc. (BPTH)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 2.3400 |
| Open | 2.3100 |
| Bid | 2.0900 x 100 |
| Ask | 2.2100 x 100 |
| Day's range | 2.0000 - 2.3100 |
| 52-week range | 2.0000 - 44.8000 |
| Volume | |
| Avg. volume | 1,472,555 |
| Market cap | 3.35M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -33.6300 |
| Earnings date | 13 Aug 2024 - 19 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 20.00 |
- GuruFocus.com
Bio-Path Holdings Inc (BPTH) Q1 2024 Earnings Call Transcript Highlights: Strategic Advances ...
Discover how Bio-Path Holdings Inc navigates improved clinical outcomes and financial maneuvers in the first quarter of 2024.
- Thomson Reuters StreetEvents
Q1 2024 Bio Path Holdings Inc Earnings Call
Q1 2024 Bio Path Holdings Inc Earnings Call
GlobeNewswireBio-Path Holdings Reports First Quarter 2024 Financial Results
Marks Progress Across Key Clinical and Corporate Goals Strengthened Balance Sheet with $3.5 Million Conference Call to be Held Today at 8:30 A.M. ET HOUSTON, May 15, 2024 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced its financial results for the first quarter ended March 31, 2024 and provided an update on
© 2024 Yahoo. All rights reserved.